Atrium Therapeutics, Inc. · NASDAQ:RNA
Sessa Capital IM, L.P. reported a 8.80% stake in Atrium Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Sessa Capital IM, L.P. reported a 8.80% stake in Atrium Therapeutics, Inc., 1,500,000 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 8.80%
- Shares
- 1,500,000
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Sessa Capital IM, L.P. | 8.80% | 1,500,000 |
| John Petry | 8.80% | 1,500,000 |